BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02927262-completion@plaintrial.com
DTSTAMP:20261028T041212Z
DTSTART;VALUE=DATE:20240219
SUMMARY:A Study of ASP2215 (Gilteritinib)\, Administered as Maintenance The
 rapy Following Induction/Consolidation Therapy for Subjects With FMS-like 
 Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complet
 e Remission — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02927262
URL:https://plaintrial.com/trial/NCT02927262
END:VEVENT
END:VCALENDAR